First results of the Phase III GIMEMA ALL2820 trial comparing ponatinib plus blinatumomab to imatinib and chemotherapy for newly diagnosed adult ph+ acute lymphoblastic leukemia patientsSabina Chiaretti, Paola Fazi, Cristina Skert et al.|Blood|2025Cited by 12